Also trades as: BLRX.TA (TLV) · $vol 0M
BLRX NASDAQ
BioLineRx Ltd.
1W: -8.8%
1M: -13.5%
3M: -25.0%
YTD: -15.4%
1Y: -38.8%
3Y: -97.1%
5Y: -98.0%
$2.37
+0.02 (+0.85%)
Weekly Expected Move ±6.1%
$2
$2
$2
$3
$3
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$41M
+5.1% ▲
5Y CAGR: -2.9%
Total Liabilities
$18M
-31.0% ▼
5Y CAGR: -7.0%
Shareholders Equity
$18M
+35.2% ▲
5Y CAGR: -3.8%
Cash & Investments
$21M
+6.7% ▲
5Y CAGR: -1.6%
Total Debt
$10M
-32.5% ▼
5Y CAGR: +5.7%
Net Debt
$7M
+49.9% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $13M | $11M | $4M | $10M | $3M |
| Short-Term Investments | $44M | $40M | $39M | $9M | $18M |
| Cash & ST Investments | $57M | $51M | $43M | $20M | $21M |
| Net Receivables | $142K | $721K | $708K | $4M | $456K |
| Inventory | $127K | $197K | $2M | $3M | $2M |
| Other Current Assets | -$127K | -$197K | $480K | $0 | $0 |
| Total Current Assets | $57M | $52M | $47M | $27M | $24M |
| Property, Plant & Equip. | $2M | $2M | $2M | $1M | $856K |
| Goodwill & Intangibles | $22M | $22M | $15M | $10M | $16M |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Assets | $0 | $0 | $0 | $0 | $0 |
| Total Non-Current Assets | $24M | $24M | $17M | $12M | $17M |
| Total Assets | $81M | $76M | $64M | $39M | $41M |
| — Liabilities — | |||||
| Accounts Payable | $6M | $7M | $11M | $6M | $3M |
| Short-Term Debt | $3M | $2M | $3M | $4M | $5M |
| Deferred Revenue | $0 | $0 | $13M | $0 | $0 |
| Other Current Liabilities | $2K | $84K | $12M | $2M | $3M |
| Total Current Liabilities | $10M | $11M | $43M | $15M | $12M |
| Long-Term Debt | $0 | $9M | $7M | $9M | $4M |
| Other Non-Current Liab. | $2M | $5M | $12M | $0 | $0 |
| Total Non-Current Liabilities | $4M | $15M | $20M | $10M | $5M |
| Total Liabilities | $13M | $26M | $51M | $25M | $18M |
| — Equity — | |||||
| Common Stock | $21M | $27M | $31M | $38M | $73M |
| Retained Earnings | -$305M | -$330M | -$391M | -$400M | -$401M |
| Accumulated OCI | $13M | $15M | $17M | $16M | $18M |
| Total Stockholders Equity | $68M | $51M | $13M | $13M | $18M |
| Total Liabilities & Equity | $81M | $76M | $64M | $39M | $41M |
| — Key Metrics — | |||||
| Total Debt | $5M | $12M | $12M | $15M | $10M |
| Net Debt | -$8M | $2M | $7M | $5M | $7M |
| Total Investments | $44M | $40M | $39M | $9M | $18M |